Bristol-Myers (BMY), WuXi PharmaTech (WX) Enter Small-Molecule Entity Partnership

March 7, 2011 8:06 AM EST Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) and WuXi PharmaTech (NYSE: WX) enter partnership to conduct stability studies of small-molecule new chemical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login